User fees edge closer in Canada amid continued resistance from industry
This article was originally published in Clinica
Executive Summary
Once Health Canada's programme to recover device review and registration costs from industry is fully in place next year, companies will bear around 70% - or Can$8 million ($6 million) - of the Therapeutic Products Programme's total annual costs. "That's higher than any other industry," says Dennis Bryant, president of device industry association MEDEC.